Show simple item record

dc.contributor.authorRichardson, Kathryn
dc.contributor.authorWharton, Stephen B
dc.contributor.authorGrossi, Carlota M.
dc.contributor.authorMatthews, Fiona E.
dc.contributor.authorFox, Chris
dc.contributor.authorMaidment, Ian
dc.contributor.authorLoke, Yoon K
dc.contributor.authorSteel, Nicholas
dc.contributor.authorArthur, Antony
dc.contributor.authorMyint, Phyo Kyaw
dc.contributor.authorBoustani, Malaz
dc.contributor.authorCampbell, Noll
dc.contributor.authorRobinson, Louise
dc.contributor.authorRobinson, Louise
dc.contributor.authorBrayne, Carol
dc.contributor.authorSavva, George M.
dc.date.accessioned2020-03-04T11:15:01Z
dc.date.available2020-03-04T11:15:01Z
dc.date.issued2020-04-07
dc.identifier156241164
dc.identifierea80ac09-5415-4893-bf3d-6b4efad50c96
dc.identifier32116256
dc.identifier32116256
dc.identifier85083331683
dc.identifier.citationRichardson , K , Wharton , S B , Grossi , C M , Matthews , F E , Fox , C , Maidment , I , Loke , Y K , Steel , N , Arthur , A , Myint , P K , Boustani , M , Campbell , N , Robinson , L , Robinson , L , Brayne , C & Savva , G M 2020 , ' Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use ' , Journal of Alzheimer's Disease , vol. 74 , no. 3 , pp. 999-1009 . https://doi.org/10.3233/JAD-191199en
dc.identifier.issn1387-2877
dc.identifier.urihttps://hdl.handle.net/2164/13777
dc.descriptionThis research was supported by funding from the Alzheimer’s Society (AS-PG-2013-017). Work in the individual CFAS centers is supported by the UK NIHR Biomedical Research Centre for Ageing and Age – awarded to Newcastle-upon-Tyne Hospitals Foundation Trust; Cambridge Brain Bank supported by the NIHR Cambridge Biomedical Research Centre; Nottingham University Hospitals NHS Trust; University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust and Sheffield NIHR Biomedical Research Centre; The Thomas Willis Oxford Brain Collection, supported by the Oxford Biomedical Research Centre; The Walton Centre NHS Foundation Trust, Liverpool. We would like to acknowledge the essential contribution of the liaison officers, the general practitioners, their staff, and nursing and residential home staff. We are grateful to our respondents and their families for their generous gift to medical research, which has made this study possible.en
dc.format.extent11
dc.format.extent413600
dc.language.isoeng
dc.relation.ispartofJournal of Alzheimer's Diseaseen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAlzheimer’s diseaseen
dc.subjectcholinergic antagonistsen
dc.subjectbenzodiazepinesen
dc.subjectneuritic plaquesen
dc.subjectneurofibrillary tanglesen
dc.subjectneuropathologyen
dc.subjectBasal Nucleus of Meynerten
dc.subjectneurofibrillary tanglesen
dc.subjectbasal nucleus of Meynerten
dc.subjectAlzheimer's diseaseen
dc.subjectneuritic plaquesen
dc.subjectR Medicineen
dc.subjectGeriatrics and Gerontologyen
dc.subjectPsychiatry and Mental healthen
dc.subjectClinical Psychologyen
dc.subjectGeneral Neuroscienceen
dc.subject.lccRen
dc.titleNeuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Useen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.3233/JAD-191199
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85083331683&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record